Tokyo Tape
Sign in
← Japan Tobacco

Quarterly report · Q1

2914.TEDINET S100TDT5
Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥740.3bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.84T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥215.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥201.3bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥621.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥157.3bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥482.3bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥157.8bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥485.3bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥7.16Tat 2024-03-31Cons.Assets IFRS
Total assets¥7.28Tat 2023-12-31Cons.Assets IFRS
Total assets¥6.35Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.09Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥3.37Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥4.07Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥3.99Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.83Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥766.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥567.0bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥27.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥126.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥341.2bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥270.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥88.582024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥271.692023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥88.572024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥271.632023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.6%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥322m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥705m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥9.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥6m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥64m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥219.2bn
—segment totalrevenue2024-01-01 → 2024-03-31¥740.1bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥740.0bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥69m
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥225.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 891
ItemContextValueUnit
Hedge costs net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-229000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration23954000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration180028000000JPY
Other comprehensive income IFRSPrior1YTDDuration25086000000JPY
Other comprehensive income IFRSCurrentYTDDuration181248000000JPY
Comprehensive income IFRSPrior1YTDDuration170311000000JPY
Comprehensive income IFRSCurrentYTDDuration339015000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration166722000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration337642000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration3589000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration1373000000JPY
Comprehensive income IFRSPrior1YTDDuration170311000000JPY
Comprehensive income IFRSCurrentYTDDuration339015000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember100000000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember736400000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-490183000000JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember1001000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember85796000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember8546000000JPY
Equity IFRSPrior2YearInstant_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember23590000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-2564000000JPY
Other comprehensive income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember23590000000JPY
Comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-2564000000JPY
Comprehensive income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass